Sports Briefing: Wonnum joins Lions after 2-year Panthers stint Strategic angle: Free agent defensive end D.J. Wonnum signs a one-year deal with the Detroit Lions. Editorial Staff Mar 18
Money Briefing: State panel advances contract to provide ‘roadmap’ for Arkansas lithium Strategic angle: The Arkansas Democrat-Gazette reports on a significant step towards lithium development in Arkansas. Editorial Staff Mar 18
Tech Briefing: U.S. Says Anthropic Is an ‘Unacceptable’ National Security Risk Strategic angle: The New York Times reports on the U.S. government's concerns regarding Anthropic's impact on national security. Editorial Staff Mar 18
Tech Briefing: A tale about fixing eBPF spinlock issues in the Linux kernel Strategic angle: An insightful article detailing the resolution of eBPF spinlock challenges within the Linux kernel. Editorial Staff Mar 18
Tech Briefing: Justice Department Says Anthropic Can’t Be Trusted With Warfighting Systems Strategic angle: Concerns raised over Anthropic's reliability in handling military technology. Editorial Staff Mar 18
Sports Briefing: Wolves' Edwards to miss time with knee soreness Strategic angle: Timberwolves star Anthony Edwards underwent an MRI on his right knee that revealed inflammation, and he will be reevaluated in 1-2 weeks. Editorial Staff Mar 18
Sports Briefing: Pippen, Aldama have season-ending surgery Strategic angle: Memphis Grizzlies guard Scotty Pippen Jr. and forward Santi Aldama will miss the rest of the season after each had surgery on Tuesday. Editorial Staff Mar 18
Life Briefing: Researchers explore new ways to neutralize germs using light-activated nanomaterials Strategic angle: At Empa, researchers are developing innovative methods to combat harmful bacteria and viruses using advanced nanomaterials. Editorial Staff Mar 18
Money Briefing: Are Nuclear Power Plants the Key to Powering Our Digital World? Strategic angle: Exploring the role of nuclear energy in supporting the growing demands of our digital infrastructure. Editorial Staff Mar 18
Politics Briefing: India's cheap weight-loss drugs could reshape global obesity fight Strategic angle: With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market. Editorial Staff Mar 18